Zhejiang Medicine: Plans to subscribe for private fund shares worth 157 million yuan

NightAirdropper · 2026-03-10T14:14:08+00:00

Zhejiang Medicine announced that it has signed a partnership agreement with Xiamen Huaben and others to jointly invest 320 million yuan to establish Xiamen Huaben Qihang Equity Investment Partnership. The company will contribute 157 million yuan, accounting for 49.06%, mainly investing in emerging industries such as biomedicine. The registration process needs to be completed, and there are risks of returns and principal loss.

NightAirdropper

2026-03-10 14:14:08

Abstract generation in progress

Everyday Economic News AI Express, March 9th, Zhejiang Medicine announced that on March 9, 2026, the company signed a “Partnership Agreement” with Xiamen Huaben Contemporary Venture Investment Management Co., Ltd. and others to jointly invest in Xiamen Huaben Qihang Equity Investment Partnership. The total committed capital of the partnership is 320 million yuan, with the company contributing 157 million yuan in its own funds, accounting for 49.06%. The fund mainly focuses on strategic emerging industries such as biomedicine, with an investment proportion of no less than 60% of the fund size. This transaction does not constitute a related-party transaction or major asset restructuring and still requires filing procedures for the fund. Investment risks include the possibility of not achieving expected returns or even losing principal.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.